PORCELLI, LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.454
EU - Europa 318
AS - Asia 183
SA - Sud America 4
OC - Oceania 3
Totale 1.962
Nazione #
US - Stati Uniti d'America 1.446
SE - Svezia 115
CN - Cina 85
SG - Singapore 78
IT - Italia 68
GB - Regno Unito 34
DE - Germania 31
BE - Belgio 19
FR - Francia 17
FI - Finlandia 12
CA - Canada 8
VN - Vietnam 8
IN - India 6
LT - Lituania 4
NL - Olanda 4
RU - Federazione Russa 4
AU - Australia 3
BR - Brasile 3
ID - Indonesia 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
MD - Moldavia 1
MT - Malta 1
PT - Portogallo 1
RS - Serbia 1
TR - Turchia 1
Totale 1.962
Città #
Fairfield 221
Woodbridge 168
Chandler 166
Ashburn 119
Seattle 92
Houston 91
Nyköping 91
Cambridge 87
Wilmington 67
Singapore 56
Ann Arbor 49
Bari 33
Beijing 28
New York 28
Lawrence 26
Roxbury 25
Brussels 19
Brooklyn 16
Nanjing 12
Des Moines 11
San Diego 10
Dearborn 9
Paris 9
Inglewood 8
London 7
Boardman 6
Dong Ket 6
Helsinki 6
Monmouth Junction 6
Munich 6
Miami 5
Falls Church 4
Los Angeles 4
Nanchang 4
Napoli 4
Pune 4
Santa Clara 4
Shanghai 4
Toronto 4
Washington 4
Changsha 3
Detroit 3
Jiaxing 3
Kunming 3
Leawood 3
Marseille 3
Ottawa 3
Princeton 3
Shenyang 3
Triggiano 3
Amsterdam 2
Bitonto 2
Casoria 2
Dalmine 2
Groningen 2
Hangzhou 2
Hanoi 2
Hefei 2
Melbourne 2
Milan 2
Norwalk 2
Prescot 2
Reggio Emilia 2
San Mateo 2
Tianjin 2
Wuhan 2
Acton 1
Almaty 1
Ardabil 1
Atlanta 1
Augusta 1
Belgrade 1
Botucatu 1
Brindisi 1
Brno 1
Canberra 1
Chisinau 1
Clifton 1
Cormeilles-en-Parisis 1
Dublin 1
Esslingen am Neckar 1
Falkenstein 1
Ferrara 1
Frankfurt am Main 1
Grafing 1
Guangzhou 1
Harbin 1
Hounslow 1
Il-Madliena 1
Jacksonville 1
Jinan 1
Kansas City 1
Lanzhou 1
Lauro de Freitas 1
Lisbon 1
Markham 1
Minsk 1
Mumbai 1
New Bedfont 1
Oklahoma City 1
Totale 1.615
Nome #
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 134
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 120
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 112
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 109
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study 108
null 106
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer 99
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives 95
Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma 87
EGFR tyrosine kinases inhibitors in cancer treatment: in vitro and in vivo evidence 87
null 86
Anti-EGFR monoclonal antibody in cancer treatment: In vitro and in vivo evidence 83
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy 81
Synthetic lethality to overcome cancer drug resistance 79
p53 as the main traffic controller of the cell signaling network 79
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 77
null 71
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer 53
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 53
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 45
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 42
The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study 41
The role of non-coding RNAs as prognostic factor, predictor of drug response or resistance and pharmacological targets, in the cutaneous squamous cell carcinoma 36
Long non‐coding rna landscape in prostate cancer molecular subtypes: A feature selection approach 36
Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin-332/α3 integrin axis recovery of focal adhesion kinase ubiquitination 35
Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells 34
Microfluidic-assisted preparation of targeted ph-responsive polymeric micelles improves gemcitabine effectiveness in pdac: In vitro insights 33
Probing the interaction between cisplatin and the therapeutic monoclonal antibody trastuzumab 20
BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy 17
Gene Expression Comparison between Alcohol-Exposed Versus Not Exposed Pancreatic Ductal Adenocarcinoma Patients Reveals a Peculiar TGFβ-Related Phenotype: An Exploratory Analysis 12
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma 8
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 3
Totale 2.081
Categoria #
all - tutte 10.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020380 0 0 0 0 65 43 47 62 76 34 36 17
2020/2021358 16 28 26 20 30 29 42 20 35 48 44 20
2021/2022272 9 31 3 3 21 30 10 15 25 22 31 72
2022/2023424 40 72 28 41 37 55 11 44 67 3 11 15
2023/2024168 17 23 14 11 27 46 2 8 6 6 0 8
2024/2025158 32 13 36 42 35 0 0 0 0 0 0 0
Totale 2.081